Skin necrosis due to the extravasation of irritant anticancer agents

6Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical steroids and topical cooling agents. However, 2 weeks later, the affected area turned yellow, and the histopathological findings revealed skin necrosis of the entire dermis layer. It took two and a half months to cure the lesion. Close attention should be paid to the development of skin necrosis even when irritant anticancer agents such as gemcitabine and cisplatin are administered.

Cite

CITATION STYLE

APA

Okuda, H., Masatsugu, A., Sijimaya, T., & Arai, R. (2018). Skin necrosis due to the extravasation of irritant anticancer agents. Internal Medicine, 57(5), 757–760. https://doi.org/10.2169/internalmedicine.9329-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free